Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

zydus lifesciences limited - ramipril (unii: l35jn3i7sj) (ramiprilat - unii:6n5u4qfc3g) - ramipril 1.25 mg - ramipril tablets are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. in using ramipril, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that ramipril does not have a similar risk (see warnings). in considering use of ramipril, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see warnings, angioedema). ramipril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ace

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - ramipril -

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

invagen pharmaceuticals, inc - ramipril (unii: l35jn3i7sj) (ramipril - unii:l35jn3i7sj) - capsule - 1.25 mg - ramipril is indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. in using ramipril, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that ramipril does not have a similar risk. (see warnings. ) in considering use of ramipril, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients. (see warnings, angioedema. ) ramipril is contraindicated in patients who are hypersensitive to this product or any other angiotensin converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ace inhibitor.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ramipril -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ramipril -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ramipril -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - ramipril -

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

alter, s.a. - ramipril + hidroclorotiazida - comprimido - 5 mg + 25 mg - ramipril 5 mg ; hidroclorotiazida 25 mg - ramipril and diuretics - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

alter, s.a. - ramipril + hidroclorotiazida - comprimido - 5 mg + 25 mg - ramipril 5 mg ; hidroclorotiazida 25 mg - ramipril and diuretics - genérico - duração do tratamento: longa duração

Португал - Португалски - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

pentafarma - sociedade técnico-medicinal, s.a. - ramipril + hidroclorotiazida - comprimido - 5 mg + 25 mg - ramipril 5 mg ; hidroclorotiazida 25 mg - ramipril and diuretics - genérico - duração do tratamento: longa duração